Follow the GENOMIC HEALTH INC share price and the full directors' dealings record of the company, a listed equity based in United States. Shares trade on the US market, under the authority of SEC (Form 4). Market capitalisation: €12.3m. The latest transaction was reported on 11 February 2016 (Levée d'options). Among the most active insiders: BAKER FELIX. The full history is free.
21
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
6 ops.
Sell Volume
Fundamental score
Ranked 28,254 of 29,062 companies
11.9
score / 100
Value
1
Quality
23
FCF yld-133%
Earn yld·
EV/EBITDA·
ROE-74%
Gross mgn46%
Net mgn-93%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
GENOMIC HEALTH INC es una empresa de diagnóstico genómico que proporciona pruebas para ayudar en la toma de decisiones clínicas para el tratamiento del cáncer. Cotiza en el mercado XNAS.